|
|
|
|
|
TOKYO, June 20, 2019 - (JCN Newswire) - NEC Corporation (TSE: 6701) has announced the successful conclusion of fingerprint identification technology trials with newborn children from as young as 2 to 24 hours old in the Republic of Kenya. This trial is expected to help establish a reliable foundation for biometric authentication of newborn children in emerging countries.
 | | Collection of newborn fingerprints ensures proper registration and identification |
The ability to collect and authenticate biometric information at an early age enables authorities to provide legal identity, including birth registration, for newborn children, ensures proper identification as they are discharged from the hospital, and supports the accurate management of vaccination schedules. This demonstration capitalized on continuous field research that began in 2016, resulting in an error rate of just 0.3%(1), and was carried out in coordination with the NUITM-KEMRI Project (Nagasaki University Institute of Tropical Medicine-Kenya Medical Research Institute Project).
Currently, there are approximately 1 billion people worldwide without legal identity(2). In addition, an estimated 5.6 million children under the age of 5, including 2.6 million newborns, lose their lives each year. Most of these deaths are considered to be from illness that can be avoided through preventative measures and treatments(3).
In order to solve this problem, it is necessary to establish methods for registering and identifying newborn children as well as recording their medical history. This is especially important in regions where newborn children are often released from healthcare facilities in as few as 6 hours after birth. In addition to the importance of being able to verify the identity of children when they leave healthcare facilities, it is also vitally important to be able to confirm the vaccination schedules of children within 14 weeks of birth(4).
Moreover, as children grow and mature, this identification system can assist with ensuring that children are placed in schools at the most appropriate timing, leading to the advancement of educational opportunities.
NEC?s fingerprinting technology is designed to cause minimal stress for newborn children after caregivers have provided informed consent to taking their children's biometric data.
This initiative helps to promote the 17 Sustainable Development Goals (SDGs) established by the United Nations, particularly Goal 16, Target 16.9: By 2030, provide legal identity for all, including birth registration(5).
Going forward, NEC aims to provide this technology for practical use within biometric authentication infrastructure and national identity systems in emerging countries throughout the world. In addition, it hopes to centralize the authentication of patients who visit public hospitals and to enable convenient access to their medical history. This will help to minimize the loss of medical information and to prevent errors in treatment due to lack of patient information. This information may also contribute to the understanding of civil registration and vital statistics (CRVS) in the near future.
NEC has positioned the safety business centered on Bio-IDiom(6) as a global-growth engine in its 2020 Mid-term Management Plan, a three-year medium-term management plan up to FY2020. NEC has also strengthened business under the NEC Safer Cities(7) initiative. In the future, NEC will continue to focus on the Safety Business to expand its social solutions business.
Overview of technology enhancements in testing trials
Improved Imaging Accuracy
In order to collect the fingerprints of newborn children within a few hours of being born, NEC adopted a high-resolution image sensor with a high-resolution imaging element of 10 micrometers, and combined special glass for enhancing patterns. This made it possible to capture high-definition images of "valley line" patterns of approximately 20 micrometers.
Enhancement of imaging functions and design
In order to eliminate blurring due to the movement of newborn children's fingers during the fingerprint capturing process, the frame rate was increased from the previous 2 frames per second (fps) to a 7 fps rate, and the sensor area was equipped with a blurring prevention function. In addition, NEC adopted specialized equipment that is optimally designed for newborn children, featuring contours that ensure that children?s soft fingers are not pressed strongly against imaging surfaces and guides that ensure the most appropriate direction and position of a subject's finger.
(1) According to NEC research
(2) World Bank Group;
new windowhttp://www.worldbank.org/en/programs/id4d
(3) UNICEF; "Levels & Trends in Child Mortality Report 2017" P1, October 2017
(4) UNICEF; https://www.unicef.org/immunization/index_75054.html
(5) United Nations, "General assembly 15-15900 (E) "p.26, September 2015.
(6) Bio-IDiom
"Bio-IDiom" is NEC's portfolio of biometric identification solutions, including face, iris, fingerprint, palm print, finger vein, voice, and ear acoustic solutions.
https://www.nec.com/en/global/solutions/biometrics/index.html
(7) NEC Safer Cities:
NEC's business domain supporting the realization of safe, secure, efficient, and fair cities by utilizing advanced AI and IoT-related technologies, including biometric certification and video analysis. https://www.nec.com/en/global/solutions/safercities/index.html
Contact:
NEC
Seiichiro Toda
s-toda@cj.jp.nec.com
+81-3-3798-6511
Topic: Press release summary
Source: NEC Corporation
Sectors: Electronics, CyberSecurity
https://www.acnnewswire.com
From the Asia Corporate News Network
Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
|
|
|
|
|
|
| |
| NEC Corporation Related News |
|
| 2024年4月16日 14時00分 JST |
| NEC、SBTiからNet-Zero目標の認定を取得 |
|
| Thursday, 11 April 2024, 15:10 JST |
| DOCOMO, NTT, NEC and Fujitsu Develop Top-level Sub-terahertz 6G Device Capable of Ultra-high-speed 100 Gbps Transmission |
|
| Wednesday, 10 April 2024, 13:36 JST |
| Transgene and NEC Present First Clinical Benefits of Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer at AACR 2024 |
|
| Monday, 8 April 2024, 13:45 JST |
| NEC white paper proposes comprehensive process workflow for the application of AI-driven personalized cancer vaccines |
|
| Monday, 25 March 2024, 10:08 JST |
| NEC develops marketing strategy planning & effectiveness simulation technology using generative AI |
|
| More news >> |
|
|
|
